ANI Pharmaceuticals
ANIP
ANIP
173 hedge funds and large institutions have $424M invested in ANI Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 28 closing their positions.
Holders
173
Holders Change
-11
Holders Change %
-5.98%
% of All Funds
3.96%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
66
Reduced
53
Closed
28
Calls
$2.93M
Puts
$2.3M
Net Calls
+$638K
Net Calls Change
-$4.23M
Top Buyers
| 1 |
MP
1
Mangrove Partners
Greenwich,
Connecticut
|
$29M |
| 2 |
2
First Manhattan
New York
|
$12.2M |
| 3 |
3
Ameriprise
Minneapolis,
Minnesota
|
$7.95M |
| 4 |
PFC
4
Phocas Financial Corp
Alameda,
California
|
$5.47M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$9.84M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
201
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
1IA
202
1834 Investment Advisors
Milwaukee,
Wisconsin
| $0 | 1 | – | – |
|
203
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 5 | – | – |
|
|
VCM
204
Versant Capital Management
Phoenix,
Arizona
| $0 | 10 | – | – |
|
|
CAG
205
Csenge Advisory Group
Clearwater,
Florida
| $0 | 2 | +2 | New |
|